Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs
Go back to Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs| (AMEX: DTCFF) | Delayed: 0.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.37 | 52 Week High | $ | |||
| Open | $0.37 | 52 Week Low | $ | |||
| Day High | $0.37 | P/E | N/A | |||
| Day Low | $0.37 | EPS | $ | |||
| Volume | 2,596 | |||||

